278 related articles for article (PubMed ID: 33289169)
1. Neutrophils mediate Th17 promotion in COVID-19 patients.
Parackova Z; Bloomfield M; Klocperk A; Sediva A
J Leukoc Biol; 2021 Jan; 109(1):73-76. PubMed ID: 33289169
[TBL] [Abstract][Full Text] [Related]
2. Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.
Katayama H
Bioessays; 2021 Feb; 43(2):e2000232. PubMed ID: 33166093
[TBL] [Abstract][Full Text] [Related]
3. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019.
Shahbazi M; Jafari M; Moulana Z; Sepidarkish M; Bagherzadeh M; Rezanejad M; Mirzakhani M; Javanian M; Bayani M; Sadeghi-Haddad-Zavareh M; Mehdinezhad H; Ghadimi R; Ghasemzadeh M; Shokuhi Rad A; Mohammadnia-Afrouzi M
APMIS; 2021 May; 129(5):271-279. PubMed ID: 33792109
[TBL] [Abstract][Full Text] [Related]
4. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
5. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.
Sarmiento-Monroy JC; Parra-Medina R; Garavito E; Rojas-Villarraga A
Viral Immunol; 2021 Apr; 34(3):190-200. PubMed ID: 33625297
[TBL] [Abstract][Full Text] [Related]
6. Excessive neutrophil recruitment promotes typical T-helper 17 responses in Coronavirus disease 2019 patients.
Choto TA; Makupe I; Cakana AZ; Sibanda EN; Mduluza T
PLoS One; 2022; 17(8):e0273186. PubMed ID: 35980979
[TBL] [Abstract][Full Text] [Related]
7. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.
Gil-Etayo FJ; Suàrez-Fernández P; Cabrera-Marante O; Arroyo D; Garcinuño S; Naranjo L; Pleguezuelo DE; Allende LM; Mancebo E; Lalueza A; Díaz-Simón R; Paz-Artal E; Serrano A
Front Cell Infect Microbiol; 2021; 11():624483. PubMed ID: 33718270
[TBL] [Abstract][Full Text] [Related]
8. Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
Holz K; Prinz M; Brendecke SM; Hölscher A; Deng F; Mitrücker HW; Rose-John S; Hölscher C
Front Immunol; 2018; 9():836. PubMed ID: 29770132
[TBL] [Abstract][Full Text] [Related]
9. The Role of Th17 Response in COVID-19.
Martonik D; Parfieniuk-Kowerda A; Rogalska M; Flisiak R
Cells; 2021 Jun; 10(6):. PubMed ID: 34205262
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
Pourgholaminejad A; Pahlavanneshan S; Basiri M
Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
[TBL] [Abstract][Full Text] [Related]
11. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
12. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
Kaiser R; Leunig A; Pekayvaz K; Popp O; Joppich M; Polewka V; Escaig R; Anjum A; Hoffknecht ML; Gold C; Brambs S; Engel A; Stockhausen S; Knottenberg V; Titova A; Haji M; Scherer C; Muenchhoff M; Hellmuth JC; Saar K; Schubert B; Hilgendorff A; Schulz C; Kääb S; Zimmer R; Hübner N; Massberg S; Mertins P; Nicolai L; Stark K
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34403366
[TBL] [Abstract][Full Text] [Related]
13. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
Shahbaz S; Xu L; Sligl W; Osman M; Bozorgmehr N; Mashhouri S; Redmond D; Perez Rosero E; Walker J; Elahi S
J Immunol; 2021 Aug; 207(4):1099-1111. PubMed ID: 34312258
[TBL] [Abstract][Full Text] [Related]
14. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
Bellgrau D; Modiano JF
Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
[No Abstract] [Full Text] [Related]
15. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.
Bahr F; Wehner R; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Röllig C; Schetelig J; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):357-65. PubMed ID: 23207644
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
18. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.
Azevedo MLV; Zanchettin AC; Vaz de Paula CB; Motta Júnior JDS; Malaquias MAS; Raboni SM; Neto PC; Zeni RC; Prokopenko A; Borges NH; Godoy TM; Benevides APK; de Souza DG; Baena CP; Machado-Souza C; de Noronha L
Front Immunol; 2021; 12():656350. PubMed ID: 33868301
[TBL] [Abstract][Full Text] [Related]
19. IL-25 attenuates rheumatoid arthritis through suppression of Th17 immune responses in an IL-13-dependent manner.
Liu D; Cao T; Wang N; Liu C; Ma N; Tu R; Min X
Sci Rep; 2016 Nov; 6():36002. PubMed ID: 27812008
[TBL] [Abstract][Full Text] [Related]
20. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
Rodriguez C; de Prost N; Fourati S; Lamoureux C; Gricourt G; N'debi M; Canoui-Poitrine F; Désveaux I; Picard O; Demontant V; Trawinski E; Lepeule R; Surgers L; Vindrios W; Lelièvre JD; Mongardon N; Langeron O; Cohen JL; Mekontso-Dessap A; Woerther PL; Pawlotsky JM
PLoS Pathog; 2021 Mar; 17(3):e1009416. PubMed ID: 33780519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
